Back
25
Also listed as
UMICF
OTC
Day Range
$4.70
$4.70
52-Week Range
$1.96
$6.43
Volume
1,094
50D / 200D Avg
$5.42
/
$4.57
Prev Close
$4.57
Price History
Financial Trends
Peer Comparison
vs Industrials sector median (894 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 12.3 | 14.4 |
| P/B | 2.0 | 1.9 |
| ROE % | 17.7 | 11.4 |
| Net Margin % | 2.0 | 6.5 |
| Rev Growth 5Y % | -6.2 | 8.4 |
| D/E | 1.3 | 0.6 |
Analyst Price Target
No analyst coverage available
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$0.00
$0.00 – $0.00
|
4.4 B | 0 |
| FY2029 |
$0.47
$0.46 – $0.48
|
4.2 B | 1 |
| FY2028 |
$0.54
$0.53 – $0.56
|
4 B | 1 |
Key Takeaways
Revenue declined -6.21% annually over 5 years
ROE of 17.69% — decent returns on equity
Generating 321.49M in free cash flow
P/E of 12.25 — trading at a low valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 31.49%
Cash machine — converts 87.05% of earnings into free cash flow
Growth
Revenue Growth (5Y)
-6.21%
Revenue (1Y)25.28%
Earnings (1Y)N/A
FCF Growth (3Y)42.68%
Quality
Return on Equity
17.69%
ROIC14.58%
Net Margin1.98%
Op. Margin5.31%
Safety
Debt / Equity
1.27
Current Ratio1.35
Interest Coverage6.87
Valuation
P/E Ratio
12.25
P/B Ratio2.02
EV/EBITDA5.88
Dividend Yield0.01%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 25.28% | Revenue Growth (3Y) | 0.94% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | -2.07% |
| Revenue Growth (5Y) | -6.21% | Earnings Growth (5Y) | -12.11% |
| Profitability | |||
| Revenue (TTM) | 18.61B | Net Income (TTM) | 369.32M |
| ROE | 17.69% | ROA | 3.91% |
| Gross Margin | 7.21% | Operating Margin | 5.31% |
| Net Margin | 1.98% | Free Cash Flow (TTM) | 321.49M |
| ROIC | 14.58% | FCF Growth (3Y) | 42.68% |
| Safety | |||
| Debt / Equity | 1.27 | Current Ratio | 1.35 |
| Interest Coverage | 6.87 | Dividend Yield | 0.01% |
| Valuation | |||
| P/E Ratio | 12.25 | P/B Ratio | 2.02 |
| P/S Ratio | 0.24 | PEG Ratio | -0.09 |
| EV/EBITDA | 5.88 | Dividend Yield | 0.01% |
| Market Cap | 4.52B | Enterprise Value | 5.80B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 18.61B | 14.85B | 18.27B | 25.44B | 24.05B |
| Net Income | 369.32M | -1.48B | 385.08M | 569.88M | 618.96M |
| EPS (Diluted) | 0.38 | -1.54 | 0.40 | 0.59 | 0.64 |
| Gross Profit | 1.34B | 2.21B | 1.52B | 1.67B | 1.57B |
| Operating Income | 987.33M | -1.26B | 590.68M | 818.67M | 878.94M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 9.46B | 9.41B | 9.97B | 9.94B | 9.05B |
| Total Liabilities | 7.18B | 7.49B | 6.27B | 6.38B | 5.88B |
| Shareholders' Equity | 2.24B | 1.94B | 3.66B | 3.52B | 3.11B |
| Total Debt | 2.84B | 3.45B | 2.75B | 2.35B | 2.16B |
| Cash & Equivalents | 1.56B | 2.01B | 1.52B | 1.24B | 1.19B |
| Current Assets | 5.73B | 5.61B | 5.81B | 6.55B | 5.94B |
| Current Liabilities | 4.25B | 4.35B | 3.60B | 4.13B | 3.48B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#912 of 1052
Recent Activity
Exited
Contrarian Investing (David Dreman)
Mar 25, 2026
Entered
Cash Flow Compounder
Mar 24, 2026
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026